Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer
Clinical trial NCT01207011 · COMPLETED
Trial details
- NCT number
- NCT01207011
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-06-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.